Neurologian yksikkö
Department of Neurology

Julkaisut 2005
Publications 2005

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aalto S et al. Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man.
2 Berg M et al. Multi-detector row CT angiography in the assessment of carotid artery disease in the symtomatic patients: comparison with rotaional angiography and digital subtraction angiography.
3 Bertram L et al. Family-based association between Alzheimer´s disease and variants in UBQLN1.
4 Boccardi M et al. Frontotemporal dementia as a neural system disease.
5 Bresciani L et al. Visual assessment of medial temporal atrophy on MR films in Alzheimer´s disease: comparison with volumetry.
6 Chaudhuri JD et al. Localization of M2 muscarinic receptor protein in parvalbumin and calretinin containing cells of the adult rat entorhinal cortex using two complementary methods.
7 Enberg P et al. Interaktiivinen tutkimus MS-tautia sairastavien kokemuksista hoitopalveluiden järjestämisestä Suomessa.
8 Eriksson K, Kälviäinen R. Pharmacologic management of convulsive status epilepticus in childhood.
9 Eriksson K et al. Kohtausten hoidosta epilepsian hoitoon - tunnista epilepsiaoireyhtymä.
10 Eriksson K et al. Children exposed to valproate in utero-Population based evaluation of risks and confounding factors for long-term neurocognitive development.
11 Frey HJ et al. Problems associated with biological markers of Alzheimer´s Disease.
12 Frisconi GB et al. Structural correlates of early and late onset Alzheimer`s disease: voxel based morphometric study .
13 Goncalves Pereira PM et al. MR volumetric analysis of the piriform cortex and cortical amygdala in drug-refractory temporal lobe epilepsy.
14 Halinen M et al. Sydänperäinen aivoembolisaatio.
15 Hartikainen JM et al. An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in Eastern Finland: three candidate regions found.
16 Heinonen S et al. Associations between two single nucleotide polymorphism in the adiponectin gene and polycystic ovary syndrome.
17 Herukka S-K et al. CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment.
18 Huuskonen J et al. A refined in vitro model to study inflammatory responses in organotypic membrane culture of postnatal rat hippocampal slices.
19 Ihalainen J. Regulation of Dopamine Release in the Forebrain by Alpha2 Adrenoceptors and NMDA Glutamate Receptors - A Microdialysis Study.
20 Iivonen S. Genetic and Expressional Studies of Alzheimer´s Disease Candidate Genes.
21 Iqbal K et al. Subgroups of Alzheimer´s disease based on cerebrospinal fluid molecular markers.
22 Jakovljevic´ D. The Roles of Chronobiological and Socioeconomic Factors in the Occurrence of Cerebrovascular Diseases.
23 Jones R et al. Response to letter by Bullock and Truyen.
24 Juva K et al. Alzheimerin tauti ja edunvalvonta.
25 Jäkälä P. Akuutin aivohalvauksen hoito Suomessa.
26 Kaarisalo MM et al. Diabetes worsens the outcome of acute ischemic stroke.
27 Kaarniranta K et al. Geldanamycin increases 4-hydroxynonenal (HNE)-induced cell death in human retinal pigment epithelial cells.
28 Kaarniranta K et al. Geldanamycin activates Hsp70 response and attenuates okadaic acid-induced cytotoxicity in human retinal pigment epithelial cells.
29 Kalesnykas G. Cholinergic Neurons of the Rodent Basal Forebrain and Their Content of Estrogen Receptor Alpha.
30 Kalesnykas G et al. The effect of aging on the subcellular distribution of estrogen receptor-alpha in the cholinergic neurons of transgenic and wild-type mice.
31 Karhunen H et al. Epileptogenesis after experimental focal cerebral ischemia.
32 Kivipelto M et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer´s disease.
33 Korhonen P et al. Changes in DNA binding pattern of transcription factor YY1 in neuronal degeneration.
34 Korolainen MA et al. Proteomic analysis of glial fibrillary acidic protein in Alzheimer´s disease and aging brain.
35 Kurl S et al. Cardiac power during exercise and the risk of stroke in men.
36 Kälviäinen R. Status epilepticuksen hoito - ennusteeseen voidaan vaikuttaa tehokkaalla varhaisella hoidolla.
37 Kälviäinen R et al. Refractory generalised convulsive status epilepticus - A guide to treatment.
38 Könönen M et al. Increased perfusion in motor areas after constraint-induced movement therapy in chronic stroke: a single-photon emission computerized tomography study.
39 Leonardi-Bee J et al. Dipyridamole for preventing recurrent ischemic stroke and other vascular events. A meta-analysis of individual patient data from randomized controlled trials.
40 Li W et al. Aggregation promoting C-terminal truncation of alfa-synuclein is a normal cellular process and is enhanced by the familial Parkinson´s disease-linked mutations.
41 Li X et al. Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alxheimer's disease brain.
42 Mehta PD et al. Increased serum neopterin levels in adults with Down syndrome.
43 Mehta PD, Pirttila T. Increased cerebrospinal fluid Abeta38/Abeta42 ration in Alzheimer Disease.
44 Miettinen R et al. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy.
45 Nuutinen T et al. Induction of clusterin/apoJ expression by histone deacetylase inhibitors in neural cells.
46 Parkkinen L. Impact of alpha-Synuclein Pathology on Aging.
47 Parkkinen L et al. Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.
48 Parkkinen L et al. Reply (to Alpha-synuclein aggregation and its relation to neurodegenerative diseases).
49 Parkkinen L et al. Widespread and abundant alpha-synuclein pathology in a neurologically unimpaider subject.
50 Pennanen C et al. A voxel based morphometry study on mild cognitive impairment.
51 Petersen Å et al. Orexin loss in Huntington´s disease.
52 Peurala S. Rehabilitation of Gait in Chronic Stroke Patients.
53 Peurala SH et al. The effectiveness of body weight-supported gait training and floor walking in patients with chronic stroke.
54 Peurala SH et al. Gait characteristics after gait-oriented rehabilitation in chronic stroke.
55 Pihlajamäki M et al. Distinct and overlapping fMRI activation networks for processing of novel identities and locations of objects.
56 Pirskanen M et al. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer´s disease in women.
57 Pirttilä T. Alzheimer-lääkkeiden käyttö.
58 Pirttilä T. Alzheimerin tauti ja Alzheimer-lääkkeiden käyttö.
59 Pirttilä T et al. Alzheimerin tauti ja oikeudellinen toimintakyky.
60 Pirttilä TA. The practice of dementia care: Finland.
61 Pirttilä TJ et al. Cystatin C expression is associated with granule cell dispersion in epilepsy.
62 Rahman A et al. High cholesterol diet induces tau hyperphosphorylation in apolipoprotein E deficient mice.
63 Riise Stensland HMF et al. Fine mapping of the multiple sclerosis susceptibility locus on 5p14-p12.
64 Rovio S et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease.
65 Saarela T et al. Tumour necrosis factor-alpha gene haplotype is associated with pre-eclampsia.
66 Sacco RL et al. Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations.
67 Salmenperä T et al. Hippocampal damage in newly diagnosed focal epilepsy: a prospective MRI study.
68 Sohlberg A et al. Imaging D2-receptors in quinolinic acid lesioned rat striatum with high resolution pinhole SPECT.
69 Soininen H, Pirttilä T. Onko Alzheimer-lääkkeistä hyötyä?
70 Soininen H. Muistihäiriöiden varhaisdiagnostiikka kaipaa tehostamista.
71 Soininen H et al. Can mild cognitive impairment predict Alzheimer´s disease?
72 Sorri I et al. Ophthalmologic and neurologic findings in two children exposed to vigabatrin in utero.
73 Sorri I et al. Color vision and contrast sensitivity in epilepsy patients treated with initial tiagabine monotherapy.
74 Sorri I et al. Visual function in epilepsy patients treated with initial valproate monotherapy.
75 Sotaniemi M et al. CERAD -tehtäväsarja iäkkäiden muistihäiriöpotilaiden tutkimusmenetelmänä.
76 Suomen Lastenneurologinen Yhdistys ry:n ja, Neurologinen Yhdistys ry:n asettama työryhmä. Pitkittynyt epileptinen kohtaus. Käypä hoito -suositus.
77 Suuronen T et al. Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells.
78 Tarkka IM et al. Paretic hand rehabilitation with constraint-induced movement therapy after stroke.
79 Tesco G et al. APP substitutions V715F and L720P alter PS1 conformation and dirrerentially affect Abeta and AICD generation.
80 Titianova EB et al. Footprint peak time and functional ambulation profile reflect the potential for hemiparetic gait recovery.
81 Toivonen S et al. Endothelial nitric oxide synthase polymorphism is not associated with placental abruption in finnish women.
82 van Groen T, Kadish. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.
83 van Groen T et al. Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats.
84 Vepsäläinen S et al. Genetic analysis on BDNF and TrkB gene polymorphisms in Alzheimer´s disease.
85 Wilson IA. Hippocampal Place Cells as a Window into Cognitive Aging.
86 Wilson IA et al. Age-associated alterations of hippocampal place cells are subregion specific.
87 Wilson IA et al. Place cells of aged rats in two visually identical compartments.
88 Yavich L et al. Noradrenaline overflow in mouse dentate gyrus following locus coeruleus and natural stimulation: real-time monitoring by in vivo voltammetry.
89 Yavich L et al. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated alpha-synuclein.
90 Yavich L, Ylinen A. Spreading depression in the cortex differently modulates dopamine release in rat mesolimbic and nigrostriatal terminal fields.
91 Zhang Z et al. Carotid stenosis degree in CT angiography: assessment based on luminal area versus luminal diameter measurements.
92 Zhao C. Psychotropic Medication and Functional Recovery Following Cortical Stroke in Aged Rats.
93 Zhao C et al. Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats.
94 Zhao C et al. Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury.
95 Zhao C et al. Behavioral effects of photothrombotic ischemic cortical injury in aged rats treated with the sedative-hypnotic GABAergic drug zopiclone.
96 Zhao C et al. Psychotropic medication and stroke outcome.

Neurologian yksikkö Department of Neurology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008